Business
Contract to develop AI Hub for Leukemia Care
Contract to develop AI Hub for Leukemia Care.
About this update from Pri0r1ty Intelligence Group Plc
[{"type":"text","content":"\n\n \n18th March 2025\n \nPri0r1ty Intelligence Group PLC\n(\"Pri0r1ty\" or the \"Company\")\n \nPri0r1ty Secures up to £100,000 Contract with Leukaemia Care to Develop AI-Powered Information Hub\n \nPri0r1ty Intelligence Group PLC (AIM: PR1) is pleased to announce that it has secured a significant contract with Leukaemia Care, one of the UK's leading blood cancer charities (registered charity number 1183890). The agreement, worth up to £100,000, will see Pri0r1ty AI Ltd, the company's wholly owned subsidiary, develop and implement an AI-powered information hub and website platform designed to enhance the charity's digital capabilities and improve the charities overall communication with donors and patients who are diagnosed and living with leukaemia and those around them.\n \nWith over 10,000 people diagnosed with Leukemia in the UK each year, this project will allow Pri0r1ty and Leukaemia Care to deliver tangible support, particularly for those seeking additional help for the first time. Delivering enhanced access to Leukaemia Care's sector-leading information at speed and scale for as many patients and potential supporters as possible is a fundamental goal of the project. Under the terms of the agreement, Pri0r1ty will deliver in two phases:\n \nPhase 1 will focus on creating an intuitive, user-focused information hub powered by Pri0r1ty's AI technology, with a 24/7 AI assistant to guide users to relevant information and support services. This phase will establish a comprehensive digital platform that prioritises accessibility to information, compliance with WCAG standards, and an enhanced user experience across multiple devices. This initial phase will be delivered for a fee of £50,000, part payable on signature of the agreement with the balance to be settled upon agreed milestones.\n \nPhase 2 will commence upon delivery of phase 1 and will expand the platform's capabilities to include fundraising, and charity governance features, followed by the integration of a custom CRM system to improve service delivery and data-driven decision making. This phase will be delivered for an additional fee of £50,000.\n \nLeukaemia Care selected Pri0r1ty due to the Company's expertise in AI-powered solutions and its desire to deliver cost-effective digital transformation projects for organisations o...